ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Nephrology Self-Assessment Program (NephSAP)

nephSAP: Volume 1


58 0.4MB The study of the epidemiologic aspects of glomerular disease, both primary and secondary, has been greatly facilitated by the development and implementation of "Registries" of renal disease in various countries. This valuable information may help to ident
NephSAP

Volume 1, Number 1, July 2002

Glomerular, Vascular, Tubulo-interstitial and Genetic Diseases

Gerald B. Appel, MD, FACP and Richard J. Glassock, MD, MACP
4.0 category 1 credits

The study of the epidemiologic aspects of glomerular disease, both primary and secondary, has been greatly facilitated by the development and implementation of "Registries" of renal disease in various countries. This valuable information may help to ident...




39 0.5MB Renal osteodystrophy describes the variety of metabolic bone disorders that occur as a complication of renal failure. Osteitis fibrosa cystica and osteomalacia are the two dominant forms of renal osteodystrophy, but many patients manifest mixed osteodystr
NephSAP

Volume 1, Number 2, September 2002

Renal Osteodystrophy, Disorders of Divalent Ion Metabolism, and Nephrolithiasis

Stanley Goldfarb, MD
4.0 category 1 credits

Renal osteodystrophy describes the variety of metabolic bone disorders that occur as a complication of renal failure. Osteitis fibrosa cystica and osteomalacia are the two dominant forms of renal osteodystrophy, but many patients manifest mixed osteodystr...




32 0.2MB There has been tremendous growth in the ESRD program in the United States since its inception in 1972, at which time there were less than 15,000 patients.
NephSAP

Volume 1, Number 3, November 2002

End-Stage Renal Disease and Dialysis

Jonathan Himmelfarb, MD
4.0 category 1 credits

There has been tremendous growth in the ESRD program in the United States since its inception in 1972, at which time there were less than 15,000 patients....